Clearbridge Investments, LLC Bausch Health Companies Inc. Transaction History

Clearbridge Investments, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$23.0 - $29.01 $40.7 Million - $51.3 Million	-1,769,583 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$25.04 - $30.06 $898,184 - $1.08 Million	-35,870 Reduced 1.99%	1,769,583 $49.3 Million
Q2 2021 Aug 13, 2021	SELL	$27.43 - $32.7 $2.73 Million - $3.25 Million	-99,429 Reduced 5.22%	1,805,453 $52.9 Million
Q1 2021 May 13, 2021	SELL	$21.37 - $34.38 $23,079 - $37,130	-1,080 Reduced 0.06%	1,904,882 $60.5 Million
Q4 2020 Feb 10, 2021	SELL	$15.31 - $21.12 $382,750 - $528,000	-25,000 Reduced 1.29%	1,905,962 $39.6 Million
Q3 2020 Nov 12, 2020	SELL	$14.88 - $20.13 $438,960 - $593,835	-29,500 Reduced 1.5%	1,930,962 $30 Million
Q2 2020 Aug 14, 2020	BUY	$13.31 - $20.51 $46,185 - $71,169	3,470 Added 0.18%	1,960,462 $35.9 Million
Q1 2020 May 15, 2020	SELL	$12.98 - $30.25 $43,612 - $101,640	-3,360 Reduced 0.17%	1,956,992 $30.3 Million
Q4 2019 Feb 14, 2020	SELL	$18.89 - $31.89 $13.1 Million - $22.2 Million	-695,426 Reduced 26.19%	1,960,352 $58.7 Million
Q3 2019 Nov 14, 2019	SELL	$20.88 - $25.66 $451,091 - $554,358	-21,604 Reduced 0.81%	2,655,778 $58 Million
Q2 2019 Aug 14, 2019	SELL	$20.52 - $26.45 $4.51 Million - $5.82 Million	-219,900 Reduced 7.59%	2,677,382 $0
Q1 2019 May 15, 2019	BUY	$20.23 - $26.29 $295,560 - $384,096	14,610 Added 0.51%	2,897,282 $71.6 Million
Q4 2018 Feb 14, 2019	SELL	$17.64 - $28.32 $53,890 - $86,517	-3,055 Reduced 0.11%	2,882,672 $53.2 Million
Q3 2018 Nov 14, 2018	BUY	$20.64 - $25.67 $59.6 Million - $74.1 Million	2,885,727 New	2,885,727 $74.1 Million

255

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.82B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Clearbridge Investments, LLC with notifications on news.